
A new multiple sclerosis drug has been showing quite a promise in reducing relapse rates in people who suffer from the said disease. The experimental MS drug called alemtuzumab (Lemtrada) from Genzyme has been showing that it can reduce relapse rates of MS by as much as 50 percent. It is also seen to be